Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Walgreens Boots Alliance's forward rate of return for was 5.58%.
The historical rank and industry rank for Walgreens Boots Alliance's Forward Rate of Return (Yacktman) % or its related term are showing as below:
WBA'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -5.5 Med: 11.54 Max: 18.29
Current: 6.36
During the past 13 years, Walgreens Boots Alliance's highest Forward Rate of Return was 18.29. The lowest was -5.50. And the median was 11.54.
WBA's Forward Rate of Return (Yacktman) % is ranked worse than 68.83% of 308
companies
in the Healthcare Providers & Services industry
Industry Median: 14.86
vs WBA: 6.36
Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Walgreens Boots Alliance Forward Rate of Return (Yacktman) % Historical Data
The historical data trend for Walgreens Boots Alliance's Forward Rate of Return (Yacktman) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Walgreens Boots Alliance Annual Data
Trend
Aug12
Aug13
Aug14
Aug15
Aug16
Aug17
Aug18
Aug19
Aug20
Aug21
Forward Rate of Return (Yacktman) %
11.59
12.50
17.90
10.55
-5.11
Walgreens Boots Alliance Quarterly Data
Aug17
Nov17
Feb18
May18
Aug18
Nov18
Feb19
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Forward Rate of Return (Yacktman) %
-5.00
-5.11
-0.78
2.64
5.58
Competitive Comparison
For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Walgreens Boots Alliance Forward Rate of Return (Yacktman) % Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's Forward Rate of Return (Yacktman) % distribution charts can be found below:
* The bar in red indicates where Walgreens Boots Alliance's Forward Rate of Return (Yacktman) % falls into.
Walgreens Boots Alliance Forward Rate of Return (Yacktman) % Calculation
Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
Walgreens Boots Alliance's Forward Rate of Return of May. 2022 is
Forward Rate of Return
=
Normalized Free Cash Flow
/
Price
+
5-Year EBITDA Growth Rate
=
5.08152381
/
43.83
+
-0.0601
=
5.58 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.
Be Aware
In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.
Walgreens Boots Alliance Forward Rate of Return (Yacktman) % Related Terms
Thank you for viewing the detailed overview of Walgreens Boots Alliance's Forward Rate of Return (Yacktman) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Walgreens Boots Alliance is a leading retail pharmacy chain, with over 13,000 stores in 50 states and 9 countries. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading market share of the domestic prescription drug market at about 20%. In 2021, the company sold off a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstores (40%).
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.97(2.36%) Volume: 6,891,073 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:WBA has been successfully added to your 
